HighTower Advisors LLC Sells 1,423 Shares of Chemed Co. (NYSE:CHE)

HighTower Advisors LLC lowered its stake in Chemed Co. (NYSE:CHE - Free Report) by 38.2% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,307 shares of the company's stock after selling 1,423 shares during the quarter. HighTower Advisors LLC's holdings in Chemed were worth $1,222,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. State Street Corp raised its stake in Chemed by 0.8% during the 3rd quarter. State Street Corp now owns 464,354 shares of the company's stock worth $279,063,000 after acquiring an additional 3,564 shares during the period. Geode Capital Management LLC increased its stake in shares of Chemed by 4.9% in the third quarter. Geode Capital Management LLC now owns 335,443 shares of the company's stock worth $201,820,000 after purchasing an additional 15,791 shares in the last quarter. Boston Trust Walden Corp raised its position in shares of Chemed by 10.0% during the 4th quarter. Boston Trust Walden Corp now owns 242,172 shares of the company's stock valued at $128,303,000 after purchasing an additional 22,105 shares during the period. FMR LLC lifted its stake in shares of Chemed by 23.8% during the 3rd quarter. FMR LLC now owns 238,616 shares of the company's stock valued at $143,401,000 after buying an additional 45,917 shares in the last quarter. Finally, Copeland Capital Management LLC boosted its holdings in Chemed by 16.8% in the 4th quarter. Copeland Capital Management LLC now owns 151,623 shares of the company's stock worth $80,330,000 after buying an additional 21,834 shares during the period. 95.85% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Chemed Trading Down 1.0 %

CHE traded down $6.42 during trading on Friday, hitting $605.94. 162,388 shares of the company traded hands, compared to its average volume of 93,565. The company has a market cap of $8.87 billion, a PE ratio of 30.62, a P/E/G ratio of 2.15 and a beta of 0.43. The stock's 50-day simple moving average is $574.16 and its two-hundred day simple moving average is $566.66. Chemed Co. has a 1 year low of $512.12 and a 1 year high of $642.68.

Chemed Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 0.33%. The ex-dividend date was Monday, February 24th. Chemed's dividend payout ratio is presently 10.05%.

Insiders Place Their Bets

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the business's stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $593.67, for a total value of $1,187,340.00. Following the sale, the chief executive officer now owns 102,679 shares in the company, valued at approximately $60,957,441.93. The trade was a 1.91 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP Brian C. Judkins acquired 145 shares of the stock in a transaction on Monday, December 30th. The shares were acquired at an average price of $519.50 per share, with a total value of $75,327.50. Following the transaction, the vice president now directly owns 1,678 shares of the company's stock, valued at $871,721. The trade was a 9.46 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 3.32% of the company's stock.

Wall Street Analyst Weigh In

CHE has been the topic of a number of recent analyst reports. StockNews.com raised Chemed from a "hold" rating to a "buy" rating in a report on Friday, March 7th. Royal Bank of Canada upped their price target on Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a research note on Friday, March 14th.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.